|
Site Profile
- Site Profile for Atomic Weapons Employers that Worked Uranium Metals
(Revised June 17, 2011)
 PDF 529 KB (55 pages)
Previously titled "Site Profile for Atomic Weapons Employers that Worked Uranium and Thorium Metals"
About this Document: This document provides an exposure matrix for workers at AWE facilities that performed metal-working operations with uranium metal. Over 110 facilities performed these operations, and this document intends to provide guidance for dose reconstruction at any of these facilities. The main body of this document, in Sections 2-6, includes general discussions of operations and exposure conditions at these facilities. Following the main body of this document is a collection of appendices, with one appendix for each AWE site that performed metal-working operations. Each appendix contains site-specific information that can be used for dose reconstruction. For those sites where this information is insufficient or totally lacking, the dose reconstructor must use information in the main body of the Site Profile.
Revision Includes: Incorporates review comments. Added external beta dose from surface contamination. Expanded discussion in section 3.3.1. Additional editorial changes and typographical error corrections.
Appendices:
Top of Page
Program Evaluation Reports (PERs) and Program Evaluation Plans (PEPs)
NIOSH is committed to applying the best available science in dose reconstructions. In keeping with this commitment, completed cases with probabilities of causation less than 50% are reviewed as relevant new information becomes available. The results of these reviews are described in a Program Evaluation Report (PER). The PER details the effect, if any, of the new information on the completed dose reconstruction. If it appears that the new information may result in an increase in dose for a completed dose reconstruction with a probability of causation of less than 50%, NIOSH is committed to working with the Department of Labor to reopen and rework the dose reconstruction, as appropriate. A Program Evaluation Plan (PEP) describes plans for evaluating specific program details or issues.
At the current time, no PERs or PEPs specific to Dow Chemical Company have been developed. However, we have developed PERs and PEPs that pertain to multiple sites. To view all PERs and PEPs that have been developed, please refer to the Program Evaluation Reports (PERs) and Program Evaluation Plans (PEPs) page.
Top of Page
Worker Outreach Activities
Based on a recommendation from the Advisory Board to provide workers and site experts with opportunities to participate in developing the technical documents used in dose reconstruction, NIOSH established a Worker Outreach Program.
At Worker Outreach Meetings, current and former DOE and AWE employees have opportunities to obtain information about Site Profiles, Technical Basis Documents, and Technical Information Bulletins, and to provide information for consideration and possible use in dose reconstruction. This process is valuable to ensure that the technical documents used in dose reconstruction contain correct and useful information.
Below are the Worker Outreach Activities for Dow Chemical Company:
At the current time, worker outreach activities have not been scheduled.
Top of Page
Advisory Board Work Group on SEC Issues (including the 250 day issue)
This Work Group has two primary responsibilities: 1) To serve as a review body for SEC petitions that result from NIOSH determining that it is unable to reconstruct dose for one or more individuals at a given site (83.14 SEC petition process); 2) To consider potential conditions under which significant personnel exposures might occur (in addition to criticality accidents) in short periods of time (less than 250 days) resulting in health effects. In the case of specific 83.14 petitions, the Work Group may make a recommendation to the Board either in support of the NIOSH recommendation to add a class to the SEC, or in opposition to such. In the case of the 250 day issue, the Work Group should strive to develop a position paper that can be adopted by the Board. In addition, this Work Group is also responsible for reviewing the Dow-Madison SEC petition and related documents, and developing a recommendation for the Board.
- Work Group Members
James Malcolm Melius, M.D., Dr. P.H.-Chair
Josie Beach
Mark Griffon
Genevieve S. Roessler, Ph.D.
Paul L. Ziemer, Ph.D.
- Meeting Information
- November 12, 2010
Teleconference Meeting of the Advisory Board's Work Group on SEC Issues (including the 250 day issue) Work Group
1:00 p.m. (Eastern time)
This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.
Agenda
PDF 10 KB (1 page)
Transcript
PDF 180 KB (83 pages)
Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.
- May 11, 2010
Meeting of the Advisory Board's Work Group on SEC Issues (including the 250 day issue)
Cincinnati Airport Marriott
2395 Progress Dr.
Hebron, KY 41048
(859) 586-0166
10:00 a.m. (Eastern time)
This meeting is open to the public, but without a public comment period.
Teleconference call access is available for this meeting
and it is limited only by the number of ports available.
To access the meeting via the teleconference call access,
you must dial 1-866-659-0537. To be automatically connected
to the meeting, you will need to enter the following participant
code: 9933701.
Agenda
PDF 8 KB (1 page)
Transcript
PDF 428 KB (203 pages)
Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.
- February 5, 2010
Teleconference Meeting of the Advisory Board's Work Group on SEC Issues (including the 250 day issue)
10:00 a.m. (Eastern time)
This meeting is open to the public, but without a public comment period.
Teleconference call access is available for this meeting
and it is limited only by the number of ports available.
To access the meeting via the teleconference call access,
you must dial 1-866-659-0537. To be automatically connected
to the meeting, you will need to enter the following participant
code: 9933701.
Agenda
PDF 11 KB (1 page)
Transcript
PDF 262 KB (117 pages)
Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.
- July 24, 2009
Teleconference Meeting of the Advisory Board's Work Group on SEC Issues (including the 250 day issue)
3:00 p.m. (Eastern time)
This meeting is open to the public, but without a public comment period.
Teleconference call access is available for this meeting
and it is limited only by the number of ports available.
To access the meeting via the teleconference call access,
you must dial 1-866-659-0537. To be automatically connected
to the meeting, you will need to enter the following participant
code: 9933701.
Agenda
PDF 8 KB (1 page)
Transcript
PDF 228 KB (101 pages)
Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.
- November 17, 2008
Meeting of the Advisory Board's Work Group on SEC Issues
Cincinnati Airport Marriott
2395 Progress Dr.
Hebron, KY 41048
(859) 586-0166
9:30 a.m. (Eastern time)
This meeting is open to the public, but without a public comment period.
Teleconference call access is available for this meeting
and it is limited only by the number of ports available.
To access the meeting via the teleconference call access,
you must dial 1-866-659-0537. To be automatically connected
to the meeting, you will need to enter the following participant
code: 9933701.
An agenda will be provided at a later date.
Transcript
PDF 274 KB (150 pages)
Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.
Top of Page
Comments on Dow Chemical Company Documents
How to Submit Comments
Comments on Dow Chemical Company documents can be submitted
to the NIOSH Docket Officer electronically by e-mail at
NIOCINDOCKET@cdc.gov
or printed comments can be mailed to NIOSH Docket Office,
Robert A. Taft Laboratories, MS-C34, 4676 Columbia Parkway,
Cincinnati, OH 45226. Please include the Site Profile
Number (113) on all comments.
Comments Received
- Comments from Daniel W. McKeel, Jr., M.D., on the Dow Chemical Co. (Madison Site) SEC Petition (NIOSH SEC-00079)
(February 12, 2011)
PDF 2 MB (3 pages)
- Comments from Daniel W. McKeel, Jr., M.D., on the Dow Chemical Co. (Madison Site) SEC Petition (NIOSH SEC-00079)
February 11, 2011
PDF 2 MB (3 pages)
- Comments from Daniel W. McKeel, Jr., M.D., on the Dow Chemical Co. (Madison Site) SEC Petition (NIOSH SEC-00079)
July 12, 2010
PDF 1.6 MB (108 pages)
- Comments from Daniel W. McKeel, Jr., M.D., on the Dow Chemical Co. (Madison Site) SEC Petition (NIOSH SEC-00079)
June 13, 2010
PDF 6 MB (27 pages)
- Comments from Daniel W. McKeel, Jr., M.D., on the Former Dow Chemical, Madison, IL, AWE
Facility, Including NIOSH Addendum 2 to the NIOSH SEC-00079 Evaluation; SC&A Review of Addendum 2; Appendix C to TBD-6000 and the SC&A Review
of Appendix C
May 11, 2010
PDF 717 KB (15 pages)
- Draft: Evolution of Dose Reconstruction Approach at Dow Madison and Use of Surrogate Data
Contract No. 200-2009-28555
March 2010
PDF 42 KB (7 pages)
- Draft: Resolution of SC&A Findings on Appendix C (Dow Madison) of Battelle-TBD-6000
Contract No. 200-2009-28555
March 2010
PDF 31 KB (5 pages)
- Draft: Focused Review of Appendix C to TBD-6000--Dow Chemical Company (Madison Site)
Contract No. 200-2009-28555
August 2009
PDF 151 KB (18 pages)
- Draft: Addendum 2. A Focused Review of Addendum 2 to the Dow Chemical - Madison Plant SEC Petition Evaluation Report
Contract No. 200-2004-03805
Task Order No. 5
September 2008
PDF 270 KB (22 pages)
- Draft: A Focused Review of Operations and Thorium Exposures at the Dow Chemical Company Madison Plant
Contract No. 200-2004-03805
Task Order No. 5
August 2007
PDF 862 KB (66 pages)
Top of Page
Documents Related to Dow Chemical Company
Top of Page
Special Exposure Cohort Petition Information for Dow Chemical Company
- Class Added to the SEC
Atomic Weapons Employer (AWE) employees who were monitored or should have been monitored for exposure to thorium radionuclides while working at the Dow Chemical Company site in Madison, Illinois for a number of work days aggregating at least 250 work days from January 1, 1957 through December 31, 1960, or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort.
- Classes Not Added to the SEC
All Atomic Weapons Employees who worked at Dow Chemical Company in Madison, Illinois, from January 1, 1961 through November 30, 2007
- Petitions Qualified for Evaluation
Location: Madison, Illinois
Job Titles and/or Job Duties: All Atomic Weapons Employer employees who were monitored, or should have been monitored, for exposure to
ionizing radiation while working for a number of work days aggregating at least 250 work days, either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort
Period of Employment: January 1, 1957 through December 21, 1960
- Federal Register Notice Announcing that Dow Chemical Company SEC Petition has met the Minimum Qualifications for Review and Evaluation
December 14, 2006
PDF 77 KB (1 page)
- Copy of the Petition Received
Dow Chemical Company Petition
(November 28, 2006)
PDF 4.0 MB (124 pages)
Attachments to the petition:
- SEC Petition Evaluation Report
Dow Chemical Company SEC Petition Evaluation Report
(April 13, 2007)
PDF 127 KB (18 pages)
Addendum 1 to Dow Chemical Company SEC Evaluation Report
(August 13, 2007)
PDF 137 KB (25 pages)
Addendum 2 to Dow Chemical Company SEC Evaluation Report
(June 3, 2008)
PDF 147 KB (34 pages)
- Petition Discussed by the Advisory Board
The Advisory Board discussed the petition on February 8, 2007, May 3, 2007, January 10, 2008, June 25, 2008, November 16, 2010, and February 23, 2011, during its regular meetings.
- Advisory Board Recommendation on SEC Petition
Advisory Board Recommendation on the Dow Chemical Company SEC Petition (January 1, 1957 through December 31, 1960)
(May 23, 2007)
PDF 471 KB (2 pages)
Advisory Board Recommendation on the Dow Chemical Company SEC Petition (January 1, 1961 through November 30, 2007)
(March 28, 2011)
PDF 42 KB (1 page)
- HHS Letters to Congress Regarding the SEC Petition
HHS letters to Congress Regarding the Dow Chemical Company SEC Petition (January 1, 1957 through December 31, 1960)
(June 22, 2007)
PDF 686 KB (6 pages)
HHS letters to Congress Regarding the Dow Chemical Company SEC Petition (January 1, 1961 through November 30, 2007)
(June 3, 2011)
PDF 76 KB (9 pages)
- Federal Register Notice: Designation of a Class of Employees
for Addition to the Special Exposure Cohort
Designation of a Class of Employees from Dow Chemical Company
for Addition to the Special Exposure Cohort (January 1, 1957 through December 31, 1960)
(July 11, 2007)
PDF 149 KB (2 pages)
- Federal Register Notice: Determination Concerning a Petition to Add a Class of Employees to the SEC
Federal Register Notice Announcing that a Class of Employees from Dow Chemical Company did not Meet the Statutory Criteria for Addition to the SEC (January 1, 1961 through November 30, 2007)
(June 24, 2011)
PDF 55 KB (2 pages)
- HHS Designation of Additional Members to the SEC
HHS Designation of Additional Members from Dow Chemical Company to the SEC (January 1, 1957 through December 31, 1960)
(June 22, 2007)
PDF 461 KB (4 pages)
- HHS Determination Concerning a Petition to Add Members to the SEC
HHS Determination Concerning a Petition to Add a Class of Employees from Dow Chemical Company (January 1, 1961 through November 30, 2007)
(June 3, 2011)
PDF 38 KB (4 pages)
- Effective Date for the SEC Class
July 22, 2007 (January 1, 1957 through December 31, 1960)
- Federal Register Notice: Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort
August 7, 2007 (January 1, 1957 through December 31, 1960)
PDF 79 KB (1 page)
- Letter to DOL Regarding the Addition of a New Class of Employees to the SEC
July 30, 2007 (January 1, 1957 through December 31, 1960)
PDF 25 KB (1 page)
Top of Page
Previous Versions of Dow Chemical Company (Madison) Documents
- Site Profile for Atomic Weapons Employers that Worked Uranium and Thorium Metals
(Approved December 13, 2006)
PDF 394 KB (57 pages)
About this Document: This document provides an exposure matrix for workers at AWE facilities that performed metal-working operations with uranium metal. Over 110 facilities performed these operations, and this document intends to provide guidance for dose reconstruction at any of these facilities. The main body of this document, in Sections 2-6, includes general discussions of operations and exposure conditions at these facilities. Following the main body of this document is a collection of appendices, with one appendix for each AWE site that performed metal-working operations. Each appendix contains site-specific information that can be used for dose reconstruction. For those sites where this information is insufficient or totally lacking, the dose reconstructor must use information in the main body of the Site Profile.
Top of Page
|
Search NIOSH
.gif){kind=spacer}
